COLRF: AI 评分 48/100 — AI 分析 (4月 2026)

China Medical & HealthCare Group Limited operates hospitals and related healthcare services across China, Australia, and the Philippines. The company diversifies its operations through healthcare, eldercare, property development, financial services, and securities trading.

Key Facts: AI Score: 48/100 Sector: Healthcare

公司概况

概要：

China Medical & HealthCare Group Limited, an investment holding company, operates hospitals and eldercare facilities across China, Australia, and the Philippines. With diversified operations in property development, financial services, and securities trading, the company caters to a broad healthcare and retirement market, demonstrating a modest profit margin and a notable dividend yield.

COLRF是做什么的？

China Medical & HealthCare Group Limited was incorporated in 1990 and initially operated under the name COL Capital Limited before rebranding in February 2016 to reflect its strategic focus on the healthcare sector. Headquartered in Wanchai, Hong Kong, the company has evolved into an investment holding entity with a significant presence in the healthcare industry across multiple geographies, including the People's Republic of China, Australia, and the Philippines. The company's operations are segmented into six key areas: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. This diversification allows China Medical & HealthCare Group Limited to capture value across different stages of the healthcare and real estate value chains. Its healthcare segment focuses on operating hospitals and providing medical services, while the eldercare segment caters to the growing demand for elderly care facilities and services. The company is also involved in property development, focusing on independent living units and health campuses designed for elderly care and retirement communities. These campuses include nursing homes, service apartments, independent living units, shopping malls, retail shops, and club hall facilities, creating comprehensive retirement ecosystems. Beyond healthcare and real estate, China Medical & HealthCare Group Limited also engages in financial services, including money lending, and securities trading and investments, further diversifying its revenue streams. Additionally, the company trades medical equipment and related supplies, complementing its healthcare operations.

COLRF的投资论点是什么？

China Medical & HealthCare Group Limited presents a diversified investment profile with its involvement in healthcare, eldercare, property development, and financial services. The company's operations across China, Australia, and the Philippines provide geographic diversification. With a market capitalization of $0.12 billion and a P/E ratio of 53.94, the company's valuation reflects its growth potential and current profitability. The dividend yield of 3.16% offers an income component to investors. Key growth catalysts include the increasing demand for healthcare and eldercare services in its operating regions. Potential risks include the relatively low profit margin of 1.2% and the challenges associated with operating in multiple regulatory environments. The company's beta of 0.56 suggests lower volatility compared to the broader market.

COLRF在哪个行业运营？

China Medical & HealthCare Group Limited operates within the healthcare and real estate sectors, both of which are experiencing growth driven by demographic shifts and increasing demand for healthcare services and retirement living. The global healthcare market is projected to continue expanding, fueled by aging populations and advancements in medical technology. The company's focus on eldercare aligns with the increasing demand for specialized facilities and services for seniors. Competition in the healthcare and real estate sectors is intense, with companies like AAPGV, AMEUF, CMXC, CNVCF, and COPHF vying for market share. China Medical & HealthCare Group Limited differentiates itself through its integrated approach, combining healthcare, eldercare, and property development.

Medical - Care Facilities

Healthcare

COLRF有哪些增长机遇？

Expansion of Eldercare Facilities: The increasing aging population in China and other regions presents a significant growth opportunity for China Medical & HealthCare Group Limited's eldercare segment. The company can expand its network of elderly nursing homes, service apartments, and independent living units to cater to this growing demand. The global eldercare market is projected to reach trillions of dollars in the coming years, offering substantial revenue potential. Timeline: Ongoing.
Geographic Expansion: China Medical & HealthCare Group Limited can explore opportunities to expand its operations into new geographic markets, particularly in Southeast Asia and other regions with growing demand for healthcare and eldercare services. This expansion can be achieved through acquisitions, partnerships, or greenfield developments. The timeline for geographic expansion will depend on regulatory approvals and market conditions. Timeline: Upcoming.
Development of Integrated Healthcare Campuses: The company's expertise in developing health campuses with a focus on elderly care and retirement communities provides a unique competitive advantage. China Medical & HealthCare Group Limited can leverage this expertise to develop more integrated healthcare campuses that offer a comprehensive range of services, including medical care, rehabilitation, and assisted living. Timeline: Ongoing.
Investment in Medical Technology: China Medical & HealthCare Group Limited can invest in advanced medical technology and equipment to enhance the quality of its healthcare services and attract more patients. This includes investing in telemedicine, remote monitoring, and other digital health solutions. The global market for medical technology is growing rapidly, driven by advancements in technology and increasing demand for healthcare services. Timeline: Ongoing.
Strategic Partnerships and Acquisitions: The company can pursue strategic partnerships and acquisitions to expand its service offerings, geographic reach, and market share. This includes partnering with other healthcare providers, technology companies, and real estate developers. Strategic partnerships and acquisitions can accelerate growth and create synergies. Timeline: Ongoing.

Market capitalization of $0.12 billion indicates the company's size and market value.
P/E ratio of 53.94 reflects investor expectations for future earnings growth.
Profit margin of 1.2% suggests potential areas for operational efficiency improvements.
Gross margin of 18.9% indicates the profitability of the company's core operations.
Dividend yield of 3.16% provides an income stream for investors.

COLRF提供哪些产品和服务？

Operates hospitals in China, Australia, and the Philippines.
Develops and manages eldercare facilities, including nursing homes and service apartments.
Engages in property development of independent living units and health campuses.
Provides financial services, including money lending.
Trades medical equipment and related supplies.
Invests in securities listed on overseas exchanges.

COLRF如何赚钱？

Generates revenue from hospital operations and medical services.
Earns income from the development and sale of properties.
Collects rental income from leasing residential and office properties.
Derives revenue from financial services, including interest income from lending.

Patients seeking medical care at its hospitals.
Elderly individuals and their families seeking eldercare services.
Residents of its independent living units and health campuses.
Borrowers seeking financial services.
Investors in its securities trading and investments business.

Geographic diversification across China, Australia, and the Philippines.
Integrated business model combining healthcare, eldercare, and property development.
Expertise in developing and managing health campuses for elderly care.
Established presence in the healthcare and real estate sectors.

什么因素可能推动COLRF股价上涨？

Ongoing: Expansion of eldercare facilities to meet the growing demand from the aging population.
Ongoing: Development of new health campuses with integrated healthcare services.
Upcoming: Potential acquisitions of other healthcare providers or related businesses.
Ongoing: Investment in medical technology to enhance service quality and attract more patients.

COLRF的主要风险是什么？

Ongoing: Intense competition from other healthcare providers and real estate developers.
Potential: Changes in healthcare regulations and reimbursement policies.
Potential: Economic downturns that could reduce demand for healthcare services and property.
Ongoing: Fluctuations in currency exchange rates.
Potential: Limited liquidity and price volatility due to OTC trading.

COLRF的核心优势是什么？

Diversified operations across healthcare, eldercare, property development, and financial services.
Geographic presence in China, Australia, and the Philippines.
Integrated business model with synergies between different segments.
Experience in developing and managing health campuses for elderly care.

COLRF的劣势是什么？

Relatively low profit margin of 1.2%.
Exposure to multiple regulatory environments.
Limited brand recognition compared to larger healthcare providers.
Dependence on economic conditions in its operating regions.

COLRF有哪些机遇？

Expansion of eldercare facilities to cater to the aging population.
Geographic expansion into new markets with growing demand for healthcare services.
Development of integrated healthcare campuses with a comprehensive range of services.
Investment in medical technology to enhance the quality of its healthcare services.

COLRF面临哪些威胁？

Intense competition from other healthcare providers and real estate developers.
Changes in healthcare regulations and reimbursement policies.
Economic downturns that could reduce demand for healthcare services and property.
Fluctuations in currency exchange rates.

COLRF的竞争对手是谁？

American Acquisition Partners Group V — Focuses on acquisitions in various sectors. — (AAPGV)
American Future Fuel Corporation — Operates in the alternative fuel sector. — (AMEUF)
CMC Materials Inc — Supplies materials for the semiconductor industry. — (CMXC)
Canivision Capital Corp. — Focuses on investment and capital ventures. — (CNVCF)
Clean Oil Partners, Inc. — Involved in oil refining and distribution. — (COPHF)

Key Metrics

MoonshotScore: 48/100

Company Profile

CEO: Muk Yin Kong
Headquarters: Wan Chai, HK
Employees: 2,626
Founded: 2014

AI Insight

AI analysis pending for COLRF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does China Medical & HealthCare Group Limited do?

China Medical & HealthCare Group Limited is an investment holding company that operates hospitals and eldercare facilities across China, Australia, and the Philippines. The company is also involved in property development, financial services, and securities trading. Its healthcare segment focuses on providing medical services, while its eldercare segment caters to the growing demand for elderly care facilities and services. The company's diversified business model allows it to capture value across different stages of the healthcare and real estate value chains.

What do analysts say about COLRF stock?

AI analysis is currently pending for China Medical & HealthCare Group Limited (COLRF). Therefore, a summary of analyst consensus, key valuation metrics, and growth considerations is not available at this time. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Further information will be available as the AI analysis is completed.

What are the main risks for COLRF?

China Medical & HealthCare Group Limited faces several risks, including intense competition from other healthcare providers and real estate developers. Changes in healthcare regulations and reimbursement policies could also negatively impact the company's profitability. Economic downturns could reduce demand for healthcare services and property, while fluctuations in currency exchange rates could affect its financial performance. As an OTC stock, COLRF also faces risks related to limited liquidity and price volatility.